Latest news
HALOZYME THERAPEUTICS, INC. : H.C. WAINWRIGHT RAISES TARGET PRICE TO $115 FROM $95 - BitgetBitget · Fri, 07 Aug 2026 10:34:24 GMTVTV THERAPEUTICS, INC. : H.C. WAINWRIGHT CUTS TARGET PRICE TO $42 FROM $45 - BitgetBitget · Fri, 07 Aug 2026 07:43:50 GMTLIGAND PHARMACEUTICALS, INC. : H.C. WAINWRIGHT RAISES TARGET PRICE TO $358 FROM $289 - BitgetBitget · Fri, 07 Aug 2026 03:46:19 GMTLGND Maintained by HC Wainwright & Co. -- Price Target Raised to $358 - GuruFocusGuruFocus · Thu, 06 Aug 2026 21:09:37 GMTPROTAGONIST THERAPEUTICS, INC. : H.C. WAINWRIGHT RAISES TARGET PRICE TO $167 FROM $117 - BitgetBitget · Thu, 06 Aug 2026 17:31:58 GMTORION ENERGY SYSTEMS, INC. : H.C. WAINWRIGHT RAISES TARGET PRICE TO $30 FROM $20 - BitgetBitget · Thu, 06 Aug 2026 11:13:04 GMTTHE CARLYLE GROUP INC. : BARCLAYS RAISES TARGET PRICE TO $64 FROM $57 - BitgetBitget · Thu, 06 Aug 2026 10:22:59 GMTDIANTHUS THERAPEUTICS, INC. : H.C. WAINWRIGHT RAISES TARGET PRICE TO $158 FROM $130 - BitgetBitget · Thu, 06 Aug 2026 02:09:07 GMT